122 related articles for article (PubMed ID: 18687018)
1. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): lessons learned.
Zisook S; Ganadjian K; Moutier C; Prather R; Rao S
J Clin Psychiatry; 2008 Jul; 69(7):1184-5. PubMed ID: 18687018
[No Abstract] [Full Text] [Related]
2. Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder.
Cutler JA; Rush AJ; McMahon FJ; Laje G
J Psychopharmacol; 2012 Mar; 26(3):360-7. PubMed ID: 22282879
[TBL] [Abstract][Full Text] [Related]
3. Limitations in efficacy of antidepressant monotherapy.
Rush AJ
J Clin Psychiatry; 2007; 68 Suppl 10():8-10. PubMed ID: 17900203
[TBL] [Abstract][Full Text] [Related]
4. Citalopram amplifies the influence of living conditions on mood in depressed patients enrolled in the STAR*D study.
Chiarotti F; Viglione A; Giuliani A; Branchi I
Transl Psychiatry; 2017 Mar; 7(3):e1066. PubMed ID: 28323288
[TBL] [Abstract][Full Text] [Related]
5. Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data.
Sakurai H; Suzuki T; Yoshimura K; Mimura M; Uchida H
Psychopharmacology (Berl); 2017 Aug; 234(16):2453-2461. PubMed ID: 28470399
[TBL] [Abstract][Full Text] [Related]
6. Income and attrition in the treatment of depression: a STAR*D report.
Warden D; Rush AJ; Wisniewski SR; Lesser IM; Thase ME; Balasubramani GK; Shores-Wilson K; Nierenberg AA; Trivedi MH
Depress Anxiety; 2009; 26(7):622-33. PubMed ID: 19582825
[TBL] [Abstract][Full Text] [Related]
7. What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
Warden D; Rush AJ; Wisniewski SR; Lesser IM; Kornstein SG; Balasubramani GK; Thase ME; Preskorn SH; Nierenberg AA; Young EA; Shores-Wilson K; Trivedi MH
Int J Neuropsychopharmacol; 2009 May; 12(4):459-73. PubMed ID: 18611293
[TBL] [Abstract][Full Text] [Related]
8. Family history of depression and therapeutic outcome: findings from STAR*D.
Husain MM; Rush AJ; Wisniewski SR; McClintock SM; Fava M; Nierenberg AA; Davis L; Balasubramani GK; Young E; Albala AA; Trivedi MH
J Clin Psychiatry; 2009 Feb; 70(2):185-95. PubMed ID: 19192454
[TBL] [Abstract][Full Text] [Related]
9. Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study.
Denninger JW; van Nieuwenhuizen AO; Wisniewski SR; Luther JF; Trivedi MH; Rush AJ; Gollan JK; Pizzagalli DA; Fava M
J Nerv Ment Dis; 2011 Oct; 199(10):807-10. PubMed ID: 21964277
[TBL] [Abstract][Full Text] [Related]
10. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
Leuchter AF; Husain MM; Cook IA; Trivedi MH; Wisniewski SR; Gilmer WS; Luther JF; Fava M; Rush AJ
Psychol Med; 2010 Feb; 40(2):239-51. PubMed ID: 19493369
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
Rush AJ; Bernstein IH; Trivedi MH; Carmody TJ; Wisniewski S; Mundt JC; Shores-Wilson K; Biggs MM; Woo A; Nierenberg AA; Fava M
Biol Psychiatry; 2006 Mar; 59(6):493-501. PubMed ID: 16199008
[TBL] [Abstract][Full Text] [Related]
12. Predictive socioeconomic and clinical profiles of antidepressant response and remission.
Jain FA; Hunter AM; Brooks JO; Leuchter AF
Depress Anxiety; 2013 Jul; 30(7):624-30. PubMed ID: 23288666
[TBL] [Abstract][Full Text] [Related]
13. Quality of Life, Functioning, and Depressive Symptom Severity in Older Adults With Major Depressive Disorder Treated With Citalopram in the STAR*D Study.
Steiner AJ; Recacho J; Vanle B; Dang J; Wright SM; Miller JS; Kauzor K; Reid M; Bashmi LE; Mirocha J; Danovitch I; IsHak WW
J Clin Psychiatry; 2017 Jul; 78(7):897-903. PubMed ID: 28858443
[TBL] [Abstract][Full Text] [Related]
14. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
Gaynes BN; Dusetzina SB; Ellis AR; Hansen RA; Farley JF; Miller WC; Stürmer T
J Clin Psychopharmacol; 2012 Feb; 32(1):114-9. PubMed ID: 22198447
[TBL] [Abstract][Full Text] [Related]
15. Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: implications for the research domain criteria (RDoC).
Ostergaard SD; Bech P; Trivedi MH; Wisniewski SR; Rush AJ; Fava M
J Affect Disord; 2014 Jul; 163():18-24. PubMed ID: 24836083
[TBL] [Abstract][Full Text] [Related]
16. Cross-trial prediction of treatment outcome in depression: a machine learning approach.
Chekroud AM; Zotti RJ; Shehzad Z; Gueorguieva R; Johnson MK; Trivedi MH; Cannon TD; Krystal JH; Corlett PR
Lancet Psychiatry; 2016 Mar; 3(3):243-50. PubMed ID: 26803397
[TBL] [Abstract][Full Text] [Related]
17. Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant.
Katz AJ; Dusetzina SB; Farley JF; Ellis AR; Gaynes BN; Castillo WC; Stürmer T; Hansen RA
Pharmacotherapy; 2012 Mar; 32(3):234-43. PubMed ID: 22392456
[TBL] [Abstract][Full Text] [Related]
18. Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
Wisniewski SR; Rush AJ; Nierenberg AA; Gaynes BN; Warden D; Luther JF; McGrath PJ; Lavori PW; Thase ME; Fava M; Trivedi MH
Am J Psychiatry; 2009 May; 166(5):599-607. PubMed ID: 19339358
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occurring alcohol dependence and major depression.
Adamson SJ; Sellman JD; Foulds JA; Frampton CM; Deering D; Dunn A; Berks J; Nixon L; Cape G
J Clin Psychopharmacol; 2015 Apr; 35(2):143-9. PubMed ID: 25679122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
